EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hormonal changes in PCOS

Jianmei Yang, Chen Chen iD

Journal of Endocrinology · 29.01.2024 · 261 (1)

DOI: 10.1530/joe-23-0342 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, erschienen am 29.01.2024. Verfasst von Jianmei Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Infertility, Diabetes Mellitus. Die Arbeit wurde bisher 178-mal zitiert (Crossref) und nennt 177 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a common endocrinopathy occurring in reproductive-age women. Hyperandrogenism, polycystic ovaries, chronic anovulation, and metabolic aberrations are the common features in PCOS. Hormonal changes are causing pathological symptoms in women with PCOS. The various hormone alterations in PCOS have been demonstrated. Hormones, such as insulin, growth hormones (GH), ghrelin, LEAP-2, gonadotropin-releasing hormone (GnRH), insulin, the luteinizing hormone/follicle-stimulating hormone (LH/FSH) ratio, androgens, and estrogens, are all abnormal in PCOS women. These hormones are related to metabolic disorders, such as diabetes and insulin resistance, overweight and obesity, infertility, and disturbed menstrual cycle in PCOS patients. The pathological changes of these hormones, such as increased insulin, reduced GH, increased ghrelin, and leptin resistance, result in an increased prevalence of diabetes and obesity in PCOS women. A reduced GH, increased LEAP-2 levels, high LH basal, increased LH/FSH ratio, high androgens, and low estrogen are demonstrated in PCOS and linked to infertility. This narrative review aims to clarify the changes of hormone profiles, such as insulin, GH, LH, FSH, androgens, estrogen, progesterone, ghrelin, LEAP-2, asprosin, and subfatin, in PCOS, which may reveal novel targets for better diagnosis and treatment of PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInfertilityDiabetes MellitusFemaleHumansGhrelinLuteinizing HormoneFollicle Stimulating HormoneAndrogensEstrogensInsulinObesity

Stichwörter der Autor:innen

diabetes mellitushormonehyperinsulinemiaobesitypolycystic ovary syndrome

Substanzen

GhrelinLuteinizing HormoneFollicle Stimulating HormoneAndrogensEstrogensInsulin

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Endocrinology, SBMS, Faculty of Medicine, The University of Queensland, St Lucia, Qld, Australia.

ORCID-Profile: Chen Chen

Zitieren

APA

Yang, J., & Chen, C. (2024). Hormonal changes in PCOS. Journal of Endocrinology, 261(1). https://doi.org/10.1530/joe-23-0342

Vancouver

Yang J, Chen C. Hormonal changes in PCOS. Journal of Endocrinology. 2024;261(1). doi:10.1530/joe-23-0342

BibTeX
@article{Yang2024,
  author = {Yang, Jianmei and Chen, Chen},
  title = {Hormonal changes in PCOS},
  journal = {Journal of Endocrinology},
  year = {2024},
  volume = {261},
  number = {1},
  doi = {10.1530/joe-23-0342}
}
Kostenlos starten →